Related Experiment Video
Updated: May 16, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid and lipoprotein particle profiles in patients with type 2 diabetes mellitus: A comparative study between
Chenghui Zhang1, Rong Du1, Suyuan Wang1
1Department of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.
Abstract:
The lipid profiles of highlanders and lowlanders differ. However, studies of the lipid profiles of patients with type 2 diabetes mellitus (T2DM) living at high altitudes are limited. This study aimed to compare lipid profiles and lipoprotein particles in individuals with T2DM permanently residing in the Tibetan Plateau and those residing in the lowlands. This cross-sectional study included 117 individuals with T2DM from the lowlands (n = 78) and highlands (n = 39). Demographic information, clinical features, blood biochemical indices, and standard lipid concentrations were recorded and evaluated. Low-density lipoprotein particles (LDL-Ps) and LDL subfractions were compared between the groups. Additionally, the risk for atherosclerotic cardiovascular disease (ASCVD) was assessed. The standard lipid profile and nuclear magnetic resonance-measured lipid panel showed no significant differences in terms of triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels. However, highlanders exhibited a higher mean level of LDL cholesterol (LDL-C) than lowlanders. The LDL-P mean level was significantly higher in highlanders than in lowlanders. Small-density LDL (sdLDL) showed no distinct difference between the two groups. Furthermore, the 10-year risks of ASCVD were slightly higher in highlanders than in lowlanders, although the difference was not statistically significant. Individuals with T2DM living at highland altitudes have higher LDL-C and LDL-P levels than those living in lowlands. No difference was observed in the sdLDL levels between the two populations. These discrepancies may carry profound implications for the clinical management of T2DM and the prevention of cardiovascular diseases in high-altitude areas.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...